Herbs (Global Traditional) · Pacific Islands
Manuka (Leptospermum scoparium) (Leptospermum scoparium)
Strong Evidencebotanical
Hermetica Superfood Encyclopedia
Manuka (Leptospermum scoparium) is a New Zealand tea tree containing cyclic triketones like leptospermone and flavesone that exhibit antimicrobial properties. These bioactive compounds demonstrate antibacterial activity against various pathogens through membrane disruption and enzyme inhibition mechanisms.
Manuka (Leptospermum scoparium) is a shrub native to New Zealand and parts of Australia, from which manuka oil is extracted via steam distillation of crushed leaves and terminal branches. The oil consists primarily of terpenoids including monoterpenes, sesquiterpenes, and distinctive triketones that vary by regional chemotype.
No human clinical trials, RCTs, or meta-analyses were found for manuka oil or Leptospermum scoparium extracts. Evidence is limited to compositional analyses and in vitro antimicrobial properties, with no PubMed PMIDs available for human studies.
No clinically studied dosage ranges have been established for manuka oil, extracts, or standardized forms due to absence of human trials. Standardization focuses on triketone content (≥25% w/w total) for quality control purposes only. Consult a healthcare provider before starting any new supplement.
Manuka's cyclic triketones, primarily leptospermone and flavesone, disrupt bacterial cell membranes and inhibit key enzymatic processes in pathogenic microorganisms. These compounds interfere with bacterial respiratory chain enzymes and compromise cell wall integrity. The triketone structure allows selective targeting of microbial cells while showing minimal cytotoxicity to human cells.
Current research on manuka is limited to preliminary in vitro studies examining its antimicrobial compounds. Laboratory analyses have identified significant triketone content, particularly leptospermone concentrations ranging from 200-1000mg per 100g of leaf material. No human clinical trials have been conducted to establish therapeutic efficacy, safety profiles, or optimal dosing protocols. The existing evidence base consists entirely of compositional analyses and traditional use documentation from Pacific Island cultures.
Safety data for manuka supplementation is extremely limited due to lack of human studies. Potential allergic reactions may occur in individuals sensitive to Myrtaceae family plants including tea tree or eucalyptus. No documented drug interactions exist, though theoretical concerns include potential interference with antibiotic medications due to antimicrobial properties. Pregnant and breastfeeding women should avoid manuka supplements due to insufficient safety data.